Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v3-EN | Version v2-EN | |
---|---|---|
Language | English | English |
Date Updated | 2017-08-18 | 2017-08-18 |
Drug Identification Number | 02393034 | 02393034 |
Brand name | NALOXONE HYDROCHLORIDE INJECTION | NALOXONE HYDROCHLORIDE INJECTION |
Common or Proper name | Naloxone Hydrochloride Injection | Naloxone Hydrochloride Injection |
Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
Ingredients | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE |
Strength(s) | 0.4MG | 0.4MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 1mL vial | 1mL vial |
ATC code | V03AB | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated discontinuation date | 2017-08-18 | 2017-08-18 |
Actual discontinuation date | 2017-08-18 | 2017-08-18 |
Remaining supply date | 2017-08-18 | 2017-08-18 |
Discontinuation status | To be discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | Replaced by DIN number 02455935 (Ethical) | Replaced by DIN number 02455935 (Ethical) |
Health Canada comments |